← Open Payments lookup

JOVAN POPOVICH: Open Payments

NPI 1396384707 · PEABODY, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,036 in 53 payments from 16 companies in 2025. Trend: 2023 $185 · 2024 $423 · 2025 $1,036

Food & beverage: $1,036
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.8$156
Lundbeck LLC12$148
Vanda Pharmaceuticals Inc.6$145
Otsuka America Pharmaceutical, Inc.5$106
ABBVIE INC.5$105
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$73
E.R. Squibb & Sons, L.L.C.3$60
Alkermes, Inc.2$50
Axsome Therapeutics, Inc.2$47
HARMONY BIOSCIENCES LLC1$35

Products named: REXULTI, INGREZZA, FANAPT, VRAYLAR, CAPLYTA, COBENFY, ABILIFY ASIMTUFII, Auvelity.

Industry payments across MA — which companies pay providers there.